These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23816531)

  • 1. Rapid assay for detecting gyrA and parC mutations associated with fluoroquinolone resistance in Enterobacteriaceae.
    Nakano R; Okamoto R; Nakano A; Nagano N; Abe M; Tansho-Nagakawa S; Ubagai T; Kikuchi-Ueda T; Koshio O; Kikuchi H; Ono Y
    J Microbiol Methods; 2013 Sep; 94(3):213-6. PubMed ID: 23816531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Mismatched PCR-Restriction Fragment Length Polymorphism Assay for Rapid Detection of
    Kakuta N; Nakano R; Nakano A; Suzuki Y; Tanouchi A; Masui T; Horiuchi S; Endo S; Kakuta R; Ono Y; Yano H
    Ann Lab Med; 2020 Jan; 40(1):27-32. PubMed ID: 31432636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An extended PCR-RFLP assay for detection of parC, parE and gyrA mutations in fluoroquinolone-resistant Streptococcus pneumoniae.
    Alonso R; Galimand M; Courvalin P
    J Antimicrob Chemother; 2004 Apr; 53(4):682-3. PubMed ID: 15014061
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid screening of fluoroquinolone resistance determinants in Streptococcus pneumoniae by PCR-restriction fragment length polymorphism and single-strand conformational polymorphism.
    Ip M; Chau SS; Chi F; Qi A; Lai RW
    J Clin Microbiol; 2006 Mar; 44(3):970-5. PubMed ID: 16517885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Mismatch Amplification Mutation Assay PCR and PCR-Restriction Fragment Length Polymorphism for Detection of Major Mutations in gyrA and parC of Escherichia coli Associated with Fluoroquinolone Resistance.
    Jazeela K; Chakraborty G; Shetty SS; Rohit A; Karunasagar I; Vijaya Kumar D
    Microb Drug Resist; 2019; 25(1):23-31. PubMed ID: 30036132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid detection of gyrA and parC mutations in quinolone-resistant Salmonella enterica using Pyrosequencing technology.
    Hopkins KL; Arnold C; Threlfall EJ
    J Microbiol Methods; 2007 Jan; 68(1):163-71. PubMed ID: 16934351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detection of gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae by denaturing high-performance liquid chromatography.
    Shigemura K; Shirakawa T; Okada H; Tanaka K; Udaka T; Kamidono S; Arakawa S; Gotoh A
    J Microbiol Methods; 2004 Dec; 59(3):415-21. PubMed ID: 15488283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
    Guo Y; Pei X; Liu X
    Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.
    Yokoi S; Yasuda M; Ito S; Takahashi Y; Ishihara S; Deguchi T; Maeda S; Kubota Y; Tamaki M; Fukushi H
    J Infect Chemother; 2004 Oct; 10(5):262-7. PubMed ID: 16163459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland.
    Piekarska K; Wołkowicz T; Zacharczuk K; Rzeczkowska M; Chróst A; Bareja E; Olak M; Gierczyński R
    Int J Antimicrob Agents; 2015 Mar; 45(3):238-43. PubMed ID: 25468717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
    Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
    Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA gyrase and topoisomerase IV mutations in an in vitro fluoroquinolone-resistant Coxiella burnetii strain.
    Vranakis I; Sandalakis V; Chochlakis D; Tselentis Y; Psaroulaki A
    Microb Drug Resist; 2010 Jun; 16(2):111-7. PubMed ID: 20438350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in clinical strains of fluoroquinolone-resistant Shigella in Anhui, China.
    Hu LF; Li JB; Ye Y; Li X
    J Microbiol; 2007 Apr; 45(2):168-70. PubMed ID: 17483803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of mutations in DNA gyrase and topoisomerase IV genes contributes to fluoroquinolone resistance in Vibrio cholerae O139 strains.
    Zhou Y; Yu L; Li J; Zhang L; Tong Y; Kan B
    Int J Antimicrob Agents; 2013 Jul; 42(1):72-5. PubMed ID: 23643392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
    Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
    J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones.
    Rafii F; Park M; Novak JS
    Antimicrob Agents Chemother; 2005 Feb; 49(2):488-92. PubMed ID: 15673722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First characterization of fluoroquinolone resistance in Streptococcus suis.
    Escudero JA; San Millan A; Catalan A; de la Campa AG; Rivero E; Lopez G; Dominguez L; Moreno MA; Gonzalez-Zorn B
    Antimicrob Agents Chemother; 2007 Feb; 51(2):777-82. PubMed ID: 17116660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance.
    Shimada Y; Deguchi T; Nakane K; Masue T; Yasuda M; Yokoi S; Ito S; Nakano M; Ito S; Ishiko H
    Int J Antimicrob Agents; 2010 Sep; 36(3):255-8. PubMed ID: 20580532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a point mutation in the parC gene of Mycoplasma bovirhinis associated with fluoroquinolone resistance.
    Hirose K; Kawasaki Y; Kotani K; Abiko K; Sato H
    J Vet Med B Infect Dis Vet Public Health; 2004 May; 51(4):169-75. PubMed ID: 15228551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.